Safety of sulfadoxine/pyrimethamine for intermittent preventive treatment of malaria in infants: evidence from large-scale operational research in southern Tanzania

Ceesay, 2008, Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis, Lancet, 372, 1545, 10.1016/S0140-6736(08)61654-2 O’Meara, 2008, Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya, Lancet, 372, 1555, 10.1016/S0140-6736(08)61655-4 Egan, 2005, Intermittent preventive treatment for malaria control in infants: moving towards evidence-based policy and public health action, Trop Med Int Health, 10, 815, 10.1111/j.1365-3156.2005.01474.x Aponte, 2009, Efficacy and safety of intermittent preventive treatment with sulfadoxine–pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials, Lancet, 374, 1533, 10.1016/S0140-6736(09)61258-7 Chandramohan, 2005, Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana, BMJ, 331, 727, 10.1136/bmj.331.7519.727 Grobusch, 2007, Intermittent preventive treatment against malaria in infants in Gabon—a randomized, double-blind, placebo-controlled trial, J Infect Dis, 196, 1595, 10.1086/522160 Kobbe, 2007, A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants, Clin Infect Dis, 45, 16, 10.1086/518575 Macete, 2006, Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial, J Infect Dis, 194, 276, 10.1086/505431 Mockenhaupt, 2007, Intermittent preventive treatment in infants as a means of malaria control: a randomized, double-blind, placebo-controlled trial in northern Ghana, Antimicrob Agents Chemother, 51, 3273, 10.1128/AAC.00513-07 Schellenberg, 2005, Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial, Lancet, 365, 1481, 10.1016/S0140-6736(05)66418-5 Forman, 2002, Erythema multiforme, Stevens–Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years’ experience, Drug Saf, 25, 965, 10.2165/00002018-200225130-00006 Miller, 1986, Severe cutaneous reactions among American travelers using pyrimethamine–sulfadoxine (Fansidar) for malaria prophylaxis, Am J Trop Med Hyg, 35, 451, 10.4269/ajtmh.1986.35.451 Bjorkman, 1991, Adverse reactions to sulfa drugs: implications for malaria chemotherapy, Bull World Health Organ, 69, 297 Ghislain, 2002, Treatment of severe drug reactions: Stevens–Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome, Dermatol Online J, 8, 5, 10.5070/D397D8T291 Gimnig, 2006, Severe cutaneous reactions to sulfadoxine–pyrimethamine and trimethoprim–sulfamethoxazole in Blantyre District, Malawi, Am J Trop Med Hyg, 74, 738, 10.4269/ajtmh.2006.74.738 Bergoend, 1968, Cutaneous reactions appearing during the mass prophylaxis of cerebrospinal meningitis with a long-delayed action sulfonamide (apropos of 997 cases) [in French], Ann Dermatol Syphiligr (Paris), 95, 481 Segal, 2007, Cutaneous reactions to drugs in children, Pediatrics, 120, e1082, 10.1542/peds.2005-2321 Roujeau, 1995, Medication use and the risk of Stevens–Johnson syndrome or toxic epidermal necrolysis, N Engl J Med, 333, 1600, 10.1056/NEJM199512143332404 Colebunders, 1987, Cutaneous reactions to trimethoprim–sulfamethoxazole in African patients with the acquired immunodeficiency syndrome, Ann Intern Med, 107, 599, 10.7326/0003-4819-107-4-599_2 Rzany, 1993, Incidence of Stevens–Johnson syndrome and toxic epidermal necrolysis in patients with the acquired immunodeficiency syndrome in Germany, Arch Dermatol, 129, 1059, 10.1001/archderm.129.8.1059 Armstrong Schellenberg, 2008, Health and survival of young children in southern Tanzania, BMC Public Health, 8, 194, 10.1186/1471-2458-8-194 Manzi, 2009, Intermittent preventive treatment for malaria and anaemia control in Tanzanian infants; the development and implementation of a public health strategy, Trans R Soc Trop Med Hyg, 103, 79, 10.1016/j.trstmh.2008.08.014 Mushi, 2008, Development of behaviour change communication strategy for a vaccination-linked malaria control tool in southern Tanzania, Malar J, 7, 191, 10.1186/1475-2875-7-191 Armstrong Schellenberg, 2010, Community effectiveness of intermittent preventive treatment for infants (IPTi) in rural southern Tanzania, Am J Trop Med Hyg, 82, 772, 10.4269/ajtmh.2010.09-0207 Shirima, 2007, The use of personal digital assistants for data entry at the point of collection in a large household survey in southern Tanzania, Emerg Themes Epidemiol, 4, 5, 10.1186/1742-7622-4-5 INDEPTH Network, 2006 Hayes, 2009 Whitaker, 2009, The methodology of self-controlled case series studies, Stat Methods Med Res, 18, 7, 10.1177/0962280208092342 Andrews, 2001, Does oral polio vaccine cause intussusception in infants? Evidence from a sequence of three self-controlled cases series studies in the United Kingdom, Eur J Epidemiol, 17, 701, 10.1023/A:1015691619745 Douglas, 2009, The risk of fractures associated with thiazolidinediones: a self-controlled case-series study, PLoS Med, 6, e1000154, 10.1371/journal.pmed.1000154 Farrington, 2001, MMR and autism: further evidence against a causal association, Vaccine, 19, 3632, 10.1016/S0264-410X(01)00097-4 Tata, 2005, Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?, Aliment Pharmacol Ther, 22, 175, 10.1111/j.1365-2036.2005.02543.x UNICEF. Operational research on intermittent preventive treatment of malaria in infants (IPTi): pharmacovigilance preliminary report. New York, NY: Unit of Policy and Evidence, Health Section, UNICEF; 2009. WHO. Global burden of disease: 2004 update. Geneva: World Health Organization; 2008. http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/index.html [accessed 12 August 2009].